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ABSTRACT 
 
The objective of this study was to examine the potential effects of long term 
hormone replacement therapy on cardiovascular autonomic nervous system responses to 
laboratory social stressors. The participants were 38 postmenopausal women, 18 using 
estrogen and progesterone hormone replacement therapy for at least 2 years and 20 
control participants without hormone replacement therapy. All women completed 
orthostasis (standing and sitting), then speech and math tasks (speech and math were 
counterbalanced). Cardiovascular measures of sympathetic nervous system (pre-ejection 
period, PEP) and parasympathetic nervous system (respiratory sinus arrhythmia, RSA) 
along with heart rate were collected throughout all periods (baseline, orthostasis, and 
stressors). For orthostasis, results of mixed analyses of variance (ANOVAs) showed 
expected period effects for heart rate, RSA and PEP, but no group or group by period 
interaction was significant. For the psychological stressors, period main effects were 
significant for all three variables, suggesting that the tasks were effective at inducing 
stress. Also, there was a significant interaction between group and period for RSA, 
demonstrated by greater decrease during the psychological stressor period in the group 
using HRT. The interactions between group and period for heart rate and PEP were non-
significant. These findings support the notion that HRT may slow age-related decreases 
in parasympathetic responsiveness. Furthermore, changes in vagal reactivity in relation to 
use of HRT appear to occur within mechanisms involving response and coping with 
psychological stressors, rather than mechanisms that accommodate basic physiological 
task such as orthostasis. 
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The Effect of Hormone Replacement Therapy on Cardiac Autonomic Response to 
Laboratory Stressors  
 Negative effects of stress on health have been studied from many different angles 
in the last few decades. It is now well established that response to stress, also labeled as 
stress reactivity, occurs in response to merely mild levels of either acute or chronic 
stressors. Studies haverepeatedly linked increased stress reactivity to a substantial range 
of health problems, such as insomnia (Wheatley, 1998), increased pain sensitivity to 
headaches(Cathcart, Petkov, & Pritchard, 2008), obesity (Dallman, Pecoraro & La Fleur, 
2005), suppression of the immune system (Calcagni & Elenkov, 2006), reproductive 
system setbacks (Negro-Vilar, 1993), or chronic illnesses such as diabetes (Räikkönen, 
Keltikangas-Järvinen, Adlercreutz, & Hautanen,1996) and irritable bowel syndrome 
(Whitehead, Crowell, Robinson, Heller, & Schuster, 1992). Elevated levels of 
thehormone cortisol, anestablished indicator of stress response of the neuroendocrine 
system, have been linked to a variety of somatic and emotional issues, as well as potential 
irreversible changes in the hypothalamus-pituitary-adrenal axis (HPA axis) and the 
sympathetic-adrenal-medullary axis (SAM axis) (Kudielka & Kirchbaum, 2005; Lovallo, 
Farag, Vincent, Thomas, & Wilson, 2006; Keitel et al., 2011). Perhaps the most alarming 
health consequences of stress are on the cardiovascular system.An extensive body of 
research has shown that elevated cardiovascular stress reactivity is a potential contributor 
to the development of cardiovascular disease (Bosma, Peter, Siegrist, & Marmot, 1998; 
Trieber et al., 2003).Furthermore, a low level of estrogen, the primary female sex steroid 
hormone, has been previously linked to increased risk of development of cardiovascular 
disease (Christodoulakos, Lambrinoudaki, & Botsis, 2007). 
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 The purpose of this study is to investigate whether hormone replacement therapy 
(HRT), a supplement that mimics endogenous hormones (estrogen and progesterone),is 
related tostress responses in postmenopausal women, primarily by 
examiningcardiovascular indicators ofautonomic nervous system (ANS) activity. In 
addition, this paper reviews current research findings in the area of stress on health, 
specifically the cardiovascular system; reviews some commonly used indicators of 
cardiac autonomic functioning; and discusses outcomes of studies evaluating the benefits 
and risks of HRT. 
Stress and the Autonomic Nervous System 
 The term “stress” has been operationalized in countless ways, but broadly, it can 
be described as the body’s biological reaction to change in the environment. This change 
in the environment canbe also referred to as the stressor. The stressor is typically 
perceived as a physical, psychological or social threat that generates a stress response. 
Depending on the character of the stressor such as intensity and length in time, it can be 
further classified as mild (low intensity) to severe (high intensity), and acute (short term) 
to chronic (long term). Stress responsesalter autonomic functions, which in turn initiate 
further biological, cognitive, and emotional reactions, with the purpose ofpreparing the 
body for a sudden burst of energy demand (Greenberg, 2008; Sapolsky, 2004). 
 The autonomic nervous system (ANS) stimulates changes in most of the body’s 
internal organs. In response to psychological stress, activation of the ANS is mediated by 
the cortex and limbic system, while responses to more basic, biological stressors are 
initiated by signals from the brainstem (Fitzgerald, Gruener, & Mtui, 2012). The ANS is 
further divided into two branches – the sympathetic and parasympathetic nervous 
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systems. The sympathetic nervous system (SNS) produces the fight-or-flight response 
which mediates mobilization and vigilance, primarily by a release of hormones such as 
cortisol and epinephrine (adrenaline) from the HPA and SAM axes. These chemical 
messengers then elicit increases in heart rate, respiration, and blood flow in skeletal 
muscles, pupil constriction, and reduction in digestion and reproduction. The 
parasympathetic branch (PNS) facilitates rest by slowing the heart rate and respiration, 
dilating pupils, and promoting digestion and reproduction. (Greenberg, 2008). The vagus 
nerve(cranial nerve X) is the primary mediator of parasympathetic messages to the heart. 
Previous studies have proposed that parasympathetic responsiveness, also known as vagal 
tone, should be used as an indicator of “cardiac age”(Hrushesky, Fader, Schmitt, & 
Gilbertsen, 1984). In addition, it has been shown that vagal tone negatively correlates 
with age, increasing the dependency on sympathetic control of the heart (Fukusaki, 
Kawakubo, & Yamamoto, 2000). Extended states of “fight-or-flight” under SNS, SAM 
and HPA axis control can lead to allostatic overload, and therefore instigate 
abovementioned health results (McEwen, 2000).Because vagal activation or withdrawal 
is not driven by the release of epinephrine from the adrenal medulla, it is believed to be 
less damaging to the body. Furthermore, it has been shown that its effects are shorter in 
duration than the ones of sympathetic activation (Saul & Cohen, 1994). 
 Studies have shown that the SNS and PNS work together as one, in some 
situations both being co-activated, in others being activated reciprocally (Berntson, 
Norman, Hawkley, & Cacioppo, 2008). However, a wide –range of individual factors 
influencing stress reactivity make it problematic to uncover the fundamental mechanisms 
by which the SNS and PNS interact.  
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Cardiovascular Indicators of Autonomic Nervous System Activity 
 Cardiovascular system activity can be assessed by a number of noninvasive 
methods. Biological indicators such as heart rate and changes in respiration rate are the 
most basic. More advanced measures, such as respiratory sinus arrhythmia and cardiac 
pre-ejection period are more specialized ways by which autonomic cardiac function is 
tested. In research on cardiovascular reactivity to psychological stressors, an increase in 
heart rate and respiration generally signifies sympathetic activity whereas a decrease in 
heart rate and respiration signifies parasympathetic activity. However, as described 
earlier, physiological responses to stress may vary among individuals and situations, and 
therefore understanding the underlying mechanisms that culminate in a given response 
represents a challenge. For example, Ritvanen, Louhevaara, Helin, Väisänen, and 
Hänninen (2006) found that perceived high stress periods led to elevated heart rate in 
young female teachers yet did not influence the blood pressure, whereas in older female 
teachers, it did not elevate heart rate, yet influenced blood pressure. Because the means 
by which these individual differences in stress responsesoccur are not yet well-defined, 
further investigation is required. 
 The method of impedance cardiography, first presented by Kubicek, Karnegis, 
Patterson, Witsoe, and Mattson in 1966, involves measuring ongoing changes in the 
resistance (impedance) to a small alternating current passed through the thorax. Since 
then, the method has been repeatedly used and refined in controlled experimental studies, 
and is now utilized to monitor and measure multiple different aspects of cardiac activity. 
Using the first derivative of raw impedance, which is the amount of change in the 
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impedance divided by the change in time, impedance cardiography allows the 
determination of aortic valve opening and thereby measurement of the cardiac pre-
ejection period (PEP) (Sherwood et al., 1990). PEP is defined as the difference in time 
between the initiation of leftventricular contraction (marked by the R wave of the 
electrocardiogram) and opening of the aortic valve (Woltjer, Bogaard, & deVries, 1997). 
It has been determined that the length of this time period is almost entirely determined by 
sympathetic activation, and therefore, PEP can be described as a biological indicator of 
sympathetic activation on the heart. Short PEP represents higher SNS activation, whereas 
longer PEP means decrease in SNS activity. 
 Heart rate variability (HRV) is described as the oscillation of heart beats in time 
(Stein, Bosner, Kleiger, & Conger, 1994). Some predictable variations of inter-beat 
intervals are primarily due to respiration and are a part of normal heart function. By 
recording the heart’s continuous beat-by-beat measurements and evaluating deviations 
from the mean, estimates of autonomic cardiac activity can be made. The information on 
HRV is primarily collected through electrocardiography (ECG or EKG), which measures 
the electrical output of the heart. Respiratory sinus arrhythmia (RSA) is a measure of 
HRV and an indicator of vagal activity on the heart. Berntson, Cacioppo, and Quigley 
(1993a) describe RSA as a rhythmical fluctuationin heart periods associated with 
respiration, causing acceleration of heart rate at inhalation and deceleration of heart rate 
at exhalation. Increases in RSA can be interpreted as indicating increasedvagal and 
therefore parasympathetic activity; whereas decreases in RSA can be understood as a 
decrease in vagal and therefore parasympathetic activity. Reduced vagal activity has been 
shown to diminish the ability to recover after stress (Fukusaki et al., 2000). Because RSA 
 6 
is closely linked to respiration, it is important to consider respiratory function as a 
potential confound. Ritz and Dahme (2006) have concluded that most studies on RSA 
have failed to implement respiration controls and underline the necessity to consider both 
respiration rate and tidal volume for purer measure of RSA. Other researchers suggest 
that correction of RSA values for respiration may be unnecessary under many conditions 
(Grossman, Wilhelm, & Spoerle, 2004).In general, previously conducted research lacks 
standardized operationalization of RSA and PEP, which may in turn affect the outcomes 
(Grossman et al., 2004; Sherwood et al., 1990) 
 Heart rate is frequently used to assess cardiovascular performance. In general, it 
represents the quantity of ventricular contractions, and therefore it is defined as the 
number of beats per minute (Graham, 1978). In the past, heart rate increase was primarily 
viewed as an indicator of SNS activation, but more recent studies have shown that it is 
also influenced by other aspects of the ANS (Berntson, Cacioppo, & Quigley, 1993b). 
Vagal activation, characterized by increase in RSA, leads to cardiac slowing, 
consequently decreasing the number of beats per minute. On the other hand sympathetic 
activation, and shorteningin PEP, leads to increase of the number of beats per minute 
(Drew & Sinoway, 2011). These relationships therefore are often characterized by 
negative correlation between heart rate and both PEP and RSA (Berntson et al., 1993b). 
 Both researchers and clinicians commonly use orthostatic stress tasks to assess 
basic homeostatic ANS activity on the heart. Orthostasis can be described as a body’s 
natural response to a change in body posture. Upon standing, a spontaneous response of 
ANS adjustments, such as increase in heart rate and blood pressure is required to prevent 
the body from orthostatic hypotension which is commonly manifested by fainting 
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(Perlmuter & Greenberg, 1996). As mentioned previously, brain regions responsible for 
initiation of stress responses differ based on the type of stressor (psychological vs. 
homeostatic), with orthostatic responses being controlled by the brainstem. 
Stress, Cardiovascular Disease and Sex Steroids 
 Stress-related cardiovascular disease is the number one killer in the United 
States(Sapolsky, 2004). It is characterized by a variety of symptoms, such as 
hypertension, heart beat arrhythmia, atherosclerotic plaque, thrombus formation, 
increased respiration, or heart muscle thickening, each having the potential of fatal 
consequences. Major risk factors, such as obesity, tobacco use, unhealthy diets, lack of 
physical exercise,and aging have been well established. The reviewed literature agrees 
that the prevalence of cardiovascular disease is greater in men, but also acknowledges 
that some of the abovementioned risk factors represent a greater threat for women than 
men (Roger et al., 2012; Sapolsky, 2004). For example, brain imaging studies suggest 
that greater prevalence of cardiovascular disease among men is a result of gender 
differences in limbic region activation, such as lateralization of amygdala activation as a 
response to emotional stressors (Cahill et al., 2001).On the other hand, Sapolsky (2004) 
argues that diabetes, increasing obesity, and smoking confer a greater risk of acquiring 
cardiovascular disease for women than men. Traustadóttir, Bosch, and Matt (2003) 
propose that difference in prevalence of cardiovascular disease between the sexes may 
exist due to prevailing sex hormone levels.In fact, it has been hypothesized that female 
sex hormones are likely to be protective effect against hypertension. Additionally, 
women have been shown to have better SNS regulation, but whether female sex 
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hormones play a role in that is not yet known (Hinojosa-Laborde, Chapa, Lange & 
Haywood, 1999). 
 To further investigate the idea that prevailing sex hormone levels can influence 
changes in cardiovascular activity, this study analyzes women in postmenopausal status 
and their response to short-term laboratory stressors, while measuring cardiovascular 
responses. Additionally, the widespread use and prescription of HRT necessitates further, 
more comprehensive understanding of its effect on health to help women going through 
the menopause transition to determine whether HRT is the best choice for their well-
being. 
Hormone Replacement Therapy and Health 
 Healthy women show the first signs of menopause at 50 years of age on average 
(Lignieres, & MacGregor, 2000). During this transitional period, the body undergoes 
biological changes, affecting women’s physical, and possibly their psychological state. 
Menopause is the cessation of ovarian cycling. Lack of follicular development leads to 
decreased production of the ovarian hormones estrogen and progesterone. Reduced levels 
of estrogen are believed to be the primary reason for the most commonly experienced 
symptoms, such as hot flashes, and night sweats as well as the greater risk of 
development of bone disorders such as osteoporosis (Cauley et al., 2003). Other 
commonly reported symptoms include sleep problems, headaches, heart palpitations, 
weight and mood changes, fatigue, and sexual dysfunctions, but there is less agreement 
about the etiology of these phenomena (Nappi & Lachowsky, 2009). All of these 
symptoms commonly fluctuate in severity, varying from one individual to another, 
implying multiple mechanisms which are not yet understood by researchers. Furthermore, 
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estrogen is known to modulate autonomic tone and therefore cardiac function. Several 
studies have associated low levels of estrogen and postmenopausal status with greater 
stress reactivity to laboratory stressors, potentially increasing the risk of development of 
cardiovascular disease (Saab, Matthews, Stoney, & McDonald, 1989; Rubinow & 
Girdler, 2011). 
 The most commonly prescribed treatment for alleviation of the abovementioned 
symptoms related to menopause is estrogen replacement therapy (ERT). ERT 
supplements are available in many forms, differingin the type of active ingredient (e.g. 
estriol, or estradiol), and forms of administration (e.g. oral, or transdermal patches) 
(Canderelli, Leccesse, Miller, & Uhrun Davidson, 2007).Progesterone replacement 
therapy is commonly recommended as a supplementary treatment to ERT, for women in 
menopause who have not undergone hysterectomy and still have their uterus. It serves as 
a balancer to estrogen against proliferation of the endometrium, consequently being a 
preventative measure against endometrial cancer (Douglas, Litman, White & Leslie, 
2002). This combined regimen is referred to as hormone replacement therapy (HRT). 
 The underlying principle that HRT restores estrogen and progesterone levels in 
postmenopausal women can create a general view that HRT is purely beneficial. In 
contrast to this perception, collected evidence suggests both negative and positive health 
consequences, making the use of HRT a very controversial topic. ERT has been 
repeatedly shown to alleviate many of the abovementioned symptoms accompanying 
menopause; (Canderelli et al., 2007;Manson & Martin, 2001; Stearns et al., 2002). The 
use of HRT has also been associated with elevated mood (Carranza-Lira & Valentino-
Figueroa, 1999), improved glycemic control in type II diabetes (Ferrara, Karter, 
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Ackerson, Liu, & Selby, 2001), or negating effects on osteoporosis (Cauley et al., 2003), 
colorectal cancer (Chlebowski et al., 2004) and Alzheimer’s Disease (Mulnard et al. 
2000). As for disadvantages, evidence of many studies has shown that women using HRT 
have an increased chance of developing an ovarian or breast cancer when compared to 
non-users (Clemons & Goss, 2001; Beral, 2007). HRT users may also be at increased risk 
of developing cardiovascular disorders (Rossouw et al., 2002), although this may depend 
on the mode of administration, the hormones used, the duration of use, and other factors. 
Hormone Replacement Therapy and Cardiovascular System 
 Unquestionably, the greatest diversity in the results of experimental studies is on 
clinical impacts of HRT on the cardiovascular system. Stampfer and colleagues (1991) 
found that postmenopausal women using HRT appeared to have lower incidence of 
coronary heart disease than women who did not use HRT. Moreover, use of ERT was 
shown to reduce low-density lipoprotein cholesterol and increase high-density lipoprotein 
cholesterol, essentially decreasing the risk of developing heart disease (Espeland et al., 
1998). Alternatively, Hulley and colleagues (1998) found that the use of HRT did not 
affect the occurrence rate of coronary heart disease after an average of 4.1 years follow 
up, when compared to postmenopausal women in the placebo group. Opposing results 
were found in a longitudinal experiment conducted by Women’s Health Initiative (WHI). 
This study concluded that HRT increases the risk of cardiovascular disease and stroke, 
warning that damaging effects of HRT prevail over the helpful ones (Rossouw et al., 
2002).  
 Results of studies on HRT effects on autonomic cardiovascular control are 
somewhat conflicting. Perhaps the most comprehensive study on HRT and the stress 
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response, carried out by Burleson and colleagues (1998), assessed the effects of both 
HRT and ERT alone on neuroendocrine, immune, and cardiovascular system reactions to 
brief psychological stressors. The outcome revealed that long-term use of ERT was 
related to significantly greater increase in heart rate and greater parasympathetic 
response, demonstrated by a greater decrease in RSA in response to the stress tasks. In 
contrast, in a subsequent report, Matthews, Flory, Owens, Harris, & Berga (2001) did not 
find an effect of HRT on heart rate response to stress, nor did they find an effect on PEP. 
In an experimental study by Farag and colleagues (2002), postmenopausal women were 
randomly assigned to three months of treatment (HRT, ERT alone, no hormones), and 
ANS regulation of cardiovascular responses to acute psychological stressors was 
examined by measuring heart rate, PEP, and HRV. Neither heart rate, nor PEP responses 
showed treatment effects, but high-frequency HRV, understood as a measure of vagal 
activity (Pomeranz et al., 1985), decreased more in response to stress only in the HRT 
group. Finally results of a study by Vongpatanasin, Tuncel, Mansour, Arbique, & Victor 
(2001) indicated that transdermal use of ERT decreased sympathetic activity, as indicated 
by microneurography of the peroneal nerves, in postmenopausal women. Potential 
explanations for the inconsistencies among this group of findings include different drug 
administrations (e.g. transdermal vs. oral; variations in type of estrogen, and 
progesterone), or duration of administration.  
 The current study used data collected by impedance cardiography and 
electrocardiograph to explore whether long-term use of HRT among postmenopausal 
women was related to cardiac stress reactivity to orthostatic stressors, and to further 
explore its effects on psychological stress responses by including an indicator of 
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sympathetic responding. Analyses compared heart rate, RSA, and PEP responses to the 
stressors between women using both estrogen and progesterone replacement, and women 
not using any kind of replacement therapy. Considering the reviewed literature, it was 
hypothesized that women using HRT would have higher stress reactivity during the 
psychological stress tasks, represented by greater decrease in RSA and a greater increase 
in heart rate in comparison to women without HRT. PEP was also studied, although a 
directional prediction was not made due to previous conflicting results. As noted above, 
an additional interest was how HRT might affect basic homeostatic responses of the ANS 
and how these effects may differ from effects on psychological stress responses. 
Therefore, heart rate, RSA and PEP responses to orthostatic stressors were compared 
between the two HRT groups, but no specific directional predictions were made. 
Method 
Participants 
 Thirty-eight women between the ages of 50 and 60 (M age=54.92, SD=2.76) were 
recruited from the community by flyers and newspaper advertisement. Criteria for 
participation in the study were as follows: 1) no menstrual periods for at least two 
consecutive years; 2) body mass index (BMI) (calculated as weight divided by squared 
height) not exceeding 34 (M=24.52, SD=3.34); 3) no intake of cardiovascular medication; 
4) no history of cardiovascular disease (e.g. hypertension); 5) no chronic diseases (e.g. 
cancer, diabetes, or kidney disease); and 6) low to moderate exercise; 7) no smoking or 
any other forms of tobacco use; 8) averaging less than ten caffeine and ten alcoholic 
beverages consumed per week; 9) no speech or math phobia; 10) willingness and 
capability of completing the tasks. Participants were compensated $50.00 for 
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participation. The criteria for membership in treatment groups were then further specified 
as follows: for the women in no HRT group (N=20), no use of any form of hormone 
replacement therapy for at least two consecutive years; for women in HRT group (N=18), 
use of both Premarin (an estrogen supplement containing estradiol-17β, estrone, and 
estriol, along with three additional equine estrogens, .625 mg/day) and Provera (a 
supplement comprising medroxyprogesterone acetate, a synthetic progesterone, 2.5 
mg/day[one participant took 5 mg/day]) on a daily or nearly daily basis for at least two 
consecutive years (M of HRT duration=3.86 years, SD=2.16). 
Procedure 
 All participants were asked to refrain from use of any non- prescription drugs, 
alcohol, and caffeine one day prior to their scheduled laboratory session. In addition, they 
were asked not to eat or drink anything other than water for four hours before their 
appointment.To reduce variability due to daily cycles, all laboratory sessions were 
scheduled for approximately 4:00 PM. Upon arrival, participants were given verbal 
description of tasks and measurements performed during the lab session. After answering 
additional questions and obtaining informed consent, weight, height, initial heart rate and 
blood pressure were recorded. Next, band sensors and spot sensors were attached around 
the trunk and connected to an impedance cardiograph, and a respirometer belt was 
placed. After about 30 minutes of adaptation and equipment calibration, the recording 
was started. For the baseline, participants were asked to remain as still as possible and to 
refrain from talking and moving around for a period of 5 minutes. After this baseline, 
participants performed an orthostasis task. In this task, participants stood up for a period 
of 3 minutes and then immediately sat down for 3 minutes.  
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 Following the baseline and orthostatic task, participants completed two stress 
tasks: math and speech1. To control for sequence effects, these tasks were administered in 
a counterbalanced order, as illustrated in Figure 1 (see Appendix A). Similar to the 
procedures used by Cacioppo and colleagues (1995), the second of the math or speech 
stressors immediately followed completion of the first, since the primary purpose of these 
mild brief psychological stressors was to be representative of those encountered in daily 
lives rather than to study individual differences between types of stressors. For the math 
task, participants performed a 5 minute mental arithmetic task. They were instructed to 
subtract as quickly and accurately as possible for five 1-minute increments. Participants 
were given a different number to work from each minute. Making an arithmetic error was 
noted and the participant was corrected. The method used for the speech task, was similar 
to that by Saab and colleagues (1989). It consisted of two parts: speech preparation, of 3 
minutes in duration, followed by actual speech delivery, also 3 minutes in length. To 
introduce the speech task, participants were asked to visualize a scenario that they were 
falsely accused of shoplifting a belt. After being taken to the store manager by the 
security guard, they had a chance to defend themselves. Participants were instructed to 
prepare to present specific points in their defense, such as 1) telling their side of the story; 
2) telling the manager what the security guard did wrong; 3)telling the manager why the 
security guard might have thought they stole the belt; 4) explaining how they could prove 
                                                 
1A third task (illusion task, which involves attention instead of stress) was also 
administered. Preliminary analyses indicated that this task could be omitted without 
compromising the results regarding the stress tasks. Therefore, in order to focus this 
report on the stress effects, results from the illusion task was omitted. However, the 
timing of the illusion task is illustrated in Figure 1 in order to better explain the events in 
the study.  
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that they did not steal the belt;5) describing what should happen to the security guard for 
the mistake;6) summarizing all of their points. During speech task instructions, the 
importance of using of the entire 3 minute speech delivery and making a well thought-out 
and intelligent speech was emphasized. To potentially increase the degree of evaluation 
anxiety, participants were told that the speech would be recorded and compared with the 
speeches of others. Recovery time of 7 minutes followed the completion of the math and 
speech tasks, regardless of task order. Cardiovascular measures of sympathetic and 
parasympathetic activity, heart rate and respiration were collected throughout all stress 
tasks, baseline, and recovery period. Recovery period was not analyzed for the current 
study.  
Measures 
 A Minnesota Impedance Cardiograph (Model 304B; Instrumentation for 
Medicine, Greenwich, CT) was used to measure the ECG, basal thoracic impedance (Z0), 
and the first derivative of the change in the impedance signal (dZ/dt). Disposable ECG 
spot electrodes were placed in the Lead II configuration for external ECG recording with 
the impedance cardiograph. Disposable band electrodes (Instrumentation for Medicine) 
were placed around the neck and chest in a tetrapolar configuration for impedance data 
collection (Sherwood et al., 1999). A 4-mA alternating current at 100 kHz was passed 
through the outer 2 electrodes, and Z0 and dZ/dt were recorded from the 2 inner 
electrodes. Respiration was monitored using an EZ-AMP amplifier and strain gauge 
(EPM Systems, Midlothian, VA), also placed around the trunk. 
 The impedance cardiograph and respirometer were interfaced with a 
microcomputer, and the Z0, dZ/dt, and ECG signals wereconverted to digital signals (12-
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bit A/D converter, 500 Hz for dZ/dt and ECG, 250 Hz for Z0) which were edited, 
reduced, and analyzed off-line. To minimize artifacts in recording, the ECG, dZ/dt, and 
respiration waveforms were monitored during collection. ECG was bandpass filtered (1 
Hz to 10,000 Hz) prior to digitization. Minutes were rejected if artifacts comprised more 
than 10% of the beats. The respiration signal was bandpass filtered (.12 to .40 Hz) with 
an interpolated finite impulse response filter, digitized, and edited to eliminate movement 
artifacts.  
 For respiratory sinus arrhythmia (RSA), beat-by-beat heart period data were 
transformed to a 500-ms interval time series. RSA was derived with a Porges-Bohrer 
filter and confirmed using spectral analysis (valid range .12 to .40 Hz).The impedance 
data were ensemble averaged within 1-min epochs, and each waveform was verified or 
edited prior to analyses using interactive software (Kelsey & Guethlein, 1990). The PEP 
was quantified as the time interval in milliseconds from the onset of the ECG Q-wave to 
the B-point of the dZ/dt wave. Mean heart rate, RSA, PEP, and respiration rate were 
calculated across each 1-minute period. 
 For the orthostasis task, the minute-by-minute means were averaged over the last 
2 minutes of the initial baseline, the last 2 minutes of standing, and the last 2 minutes of 
sitting, to produce means for initial baseline, standing, and sitting.For the stress task, the 
minute-by-minute means were averaged over the appropriate 2-minute task baseline and 
the 11 minutes of speech preparation, speech delivery, and math, to produce means for 
task baseline and aggregated stress.The time period used for the 2-minute task baseline 
differed depending on the sequence (see Figures 2 and 3).For sequences where the stress 
tasks occurred before the illusion task, the last 2 minutes of the sitting period served as 
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the task baseline.For sequences where the illusion task occurred before the stress tasks, 
the task baseline comprised the last 2 minutes of the post-illusion recovery period. 
Data Analysis 
 Mixed analyses of variance (ANOVAs), with period as the within-subject variable 
and HRT group as the between-subject variable, were used to analyze the data. Follow-up 
single-degree-of-freedom contrasts were used to explore significant 3-level main effects 
and significant interactions. 
 
 
Results 
Preliminary Analyses 
 Order effects. As noted above, tasks were administered in counterbalanced order 
(Figure 1).Mixed analyses of variance (ANOVAs) were conducted to explore the effects 
of task sequence (speech first vs. math first) on the dependent measures. No order effects 
were significant, nor were there any significant interactions between order and 
Figure 2.Diagram of minute order for task baseline for sequences A and B 
Figure 3.Diagram of minute order for task baseline for sequences C and D 
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group.However, for PEP, both the order effect and the interaction between order and 
period (task baseline vs. stressor) were marginally significant. Therefore task sequence 
was included in the initial analysis of stress effects on PEP. For the other analyses, task 
sequence was not included. 
Targeted Analyses 
 Psychological stress effects. To test the hypotheses that HRT was associated with 
greater heart rate and RSA reactivity, and examine potential effects on PEP, separate 
mixed ANOVAs were conducted2. For heart rate and RSA, group (No HRT vs. HRT) 
was the between-subjects variable and period (task baseline vs. stressor) was the within-
subjects variable. Means are illustrated in Figures 4, 5, and 6. For heart rate, the main 
effect of period was significant, F(1,36)=84.60, p<.001, but neither the main effect of 
group nor the group by period interaction was significant (Fs< 1.5). For RSA, the main 
effect of period was significant, F(1,36)=21.57, p<.001, as was the group by period 
interaction, F(1,36)=9.40, p=.004, whereas the main effect of group was not significant 
(F< 1). For PEP, task sequence and the interactions between task sequence and the other 
variables were included in the initial analysis. The interaction between task sequence and 
group was not significant, so task sequence was dropped from the analysis. The main 
effect of period was significant, F(1,35)=34.23, p<.001, but neither the main effect of 
group nor the group by period interaction was significant (Fs< 1).  
 The significant main effects of period for heart rate, RSA, and PEP suggest that 
the stress tasks were effective in stimulating physiological stress responses. The 
                                                 
2As noted above, some researchers maintain that respiratory amplitude and rate should be 
statistically controlled in order to obtain the most valid RSA values. Inclusion of these 
variables in the analyses did not alter the results, so they were omitted for simplicity. 
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significant interaction between group and period for RSA indicates that the group 
differed in their RSA reactivity to the stressors. Examination of the means for the 
interaction shows that the HRT group had a larger decrease in RSA (greater RSA 
reactivity) than the No HRT group. However, post-hoc probes of the interaction show 
that although task baseline RSA appeared higher and stressor RSA appeared lower in the 
HRT group than the No HRT group, these differences were not significant.  
 
Figure 4.Heart rate differences between groups in response to psychological stressors 
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Figure 5.Respiratory sinus arrhythmia differences between groups in response to 
psychological stressors 
 
Figure 6.Pre-ejection period differences between groups in response to psychological 
stressors 
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 Orthostasis effects. To investigate the possibility that HRT influenced basic 
homeostatic functions of the ANS, separate mixed ANOVAs were conducted for heart 
rate, RSA, and PEP. Group (No HRT vs. HRT) was the between-subjects variable and 
period (baseline vs. standing vs. sitting) was the within-subjects variable. Means are 
illustrated in Figures 7, 8 and 9. For heart rate, the main effect of period was significant, 
F(2,35)=54.67, p<.001, but neither the main effect of group nor the interaction was 
significant (Fs< 1). Post-hoc examination of the period main effect revealed that baseline 
was lower than standing, t = 8.51, p< .001, baseline was higher than sitting, t = 5.55, p< 
.001, and standing was higher than sitting, t = 10.32, p< .001. For RSA, the main effect of 
period was significant, F(2,35)= 12.51, p<.001, but neither the main effect of group nor 
the interaction was significant (Fs< 1). Post-hoc examination of the period main effect 
revealed that baseline was higher than standing, t = 4.36, p< .001, standing was lower 
than sitting, t = 5.07, p< .001, and baseline and sitting did not differ. For PEP, the main 
effect of period was significant, F(2,34)= 8.25, p<.001, but neither the main effect of 
group nor the interaction was significant (Fs< 1). Post-hoc examination of the period 
main effect revealed that baseline was higher than standing, t = 3.62, p = .003, standing 
was lower than sitting, t = 3.91, p = .001, and baseline and sitting did not differ.  
 The significant period effects for heart rate, RSA, and PEP reveal the expected 
patterns of homeostatic changes to compensate for changes in posture. The lack of 
significant group main effects or interactions between period and group indicate that 
HRT did not influence orthostatic responses. 
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Figure 7.Heart rate differences between groups in response to orthostasis 
 
 
Figure 8.Respiratory sinus arrhythmia differences between groups in response to 
orthostasis 
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Figure 9.Pre-ejection period differences between groups in response to orthostasis 
Discussion 
 The primary objective of the presented study was to investigate the influence of 
HRT on cardiac sympathetic and parasympathetic reactivity to orthostatic and 
psychological stressors in postmenopausal women. Biological markers of autonomic 
cardiac function, includingheart rate, RSA, and PEP were collected during all periods of 
the study. The research questions of this study were primarily guided by the conflicting 
results from previous studies on HRT and cardiovascular autonomic responses.  
Response to Psychological Stressors 
 Results from the analyses showed significant heart rate, RSA, and PEP changes 
between task baseline and stressor periods. These findings suggest that the psychological 
tasks were effective in inducing a stress response. 
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 Based on previous findings by Burleson and colleagues, it was hypothesized that 
use of HRT would result in higher heart rate reactivity to psychological stressors. In 
contrast to the hypothesis, heart rate increase did not vary significantly across groups. 
This result supports a number of previous research findings on HRT and heart rate 
(Matthews et al., 2001, Farag et al., 2002). It is noteworthy that the experiment by Farag 
and colleagues (2002), which tested the effects of short-term HRT on stress responses, 
also did not find heart rate differences between groups. Taken together, these results 
suggest that neither short- nor long-term HRT influences heart rate responses to brief 
psychological stressors in postmenopausal women. As noted above, Burleson and 
colleagues (1998), found significantly higher heart rate reactivity in women using long-
term ERT. Hypothetically, the differences in findings may be accounted for by 
differences in the supplements used (ERT vs. HRT), suggesting that the type of 
supplement may affect cardiovascular functioning post menopause. In fact, Omar, 
Ramirez and Gibson (1995) found that progesterone may attenuate the stress response in 
premenopausal women, especially during pregnancy, but whether this relationship exists 
in postmenopausal women is not known.  
 The results for RSA, the cardiovascular indicator of parasympathetic cardiac 
activity were concurrent with the hypothesis. The significant interaction between group 
and period revealed that women using HRT had a greater decrease in RSA in response to 
the stressors, thereby exhibiting greater vagal responsiveness than women without HRT. 
As mentioned previously, aging is accompanied by reduced parasympathetic 
responsiveness (Hrushesky et al., 1984). Consequently, long term use of HRT may in 
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theory produce more favorable aging of autonomic cardiovascular function in comparison 
with non-users, preserving the parasympathetic system and therefore promoting health.  
 Previous studies of HRT influences on PEP, the impedance-derived measure of 
sympathetic cardiac reactivity, are very limited. Consequently, this study made no 
directional predictions on PEP between groups. Similar to results by Farag and 
colleagues (2002), there was not a significant interaction between period and HRT group 
in PEP. Based on these findings, it is reasonable to propose that long term use of oral 
HRT does not alter sympathetic cardiac responses. A study by Vongpatanasin and 
colleagues (2001) indicated that a decrease of sympathetic response resulted from use of 
transdermal ERT. Because the current study used oral supplements of both estrogen and 
progesterone, however, the results cannot be directly compared. 
 Findings on RSA and PEP support the notion presented by Berntson and 
colleagues (2008) that the SNS and PNS do not always work together in a reciprocal 
manner. Women using HRT showed greater parasympathetic responsiveness than women 
not using HRT, while their sympathetic responsiveness did not significantly differ. These 
findings suggest that HRT may promote beneficial altering of cardiac stress response. 
Moreover, based on these results, HRT may represent a potential solution to the 
distressing idea noted by Fukusaki and colleagues (2000) that aging increases the 
dependency on sympathetic control by decrease in vagal tone.  
Response to Orthostasis 
 The significant period effects for heart rate, RSA, and PEP reveal the expected 
patterns of homeostatic adjustments to compensate for changes in posture. As noted 
above, these responses to more basic, biological stressors are initiated by signals from the 
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brainstem, whereas activation of the ANS in response to a psychological stressor is 
mediated by the cortex and limbic system (Fitzgerald et al., 2012). Thus, the lack of HRT 
effects in the orthostasis tasks suggests that if HRT influences vagal responses, its effects 
occur above the brainstem. 
Limitations 
 Perhaps the most important methodological limitation of this study is that it was 
not an experiment, and therefore the results may have been influenced by a number of 
factors in addition to the difference in HRT. Even though this study controlled for age, 
BMI, and general health, selection bias cannot be discounted. Women, who choose to 
take HRT, as compared to women who choose not to take HRT, may have characteristics 
that this study failed to recognize, and that may account for the difference in RSA 
reactivity. In other words, these women may have higher parasympathetic responsiveness 
to stress prior to using HRT. Future studies should further investigate individual 
differences between these two groups of women. Examples of such factors may include 
diet, activity level, self-reported stress level, socioeconomic status, and social support.  
 Although the current study enhances what is known about the use of long-term 
oral HRT and cardiovascular autonomic functioning, further explorations are still 
necessary. Future research should investigate whether the use of transdermal 
administration of HRT would replicate the results of the present study. Such an approach 
would rule out any potential role of first-pass metabolism (occurring with oral HRT) in 
HRT effects. Additionally, it is fundamental to consider that new, diverse supplements 
are produced and available on the market very frequently. These products may not only 
vary in types, amounts, and combinations of active ingredients (estradiol, estriol, estrone 
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or synthetic hormones), but can also have a very particular effect (beneficial or 
detrimental) on the cardiac autonomic responses and body in general.  
Conclusions 
 This study sought to acquire a better understanding of how long term use of HRT 
may impact cardiovascular health. Analyses of cardiovascular indicators of sympathetic 
and parasympathetic cardiovascular stress reactivity between groups concluded that the 
use of HRT does not alter heart rate or sympathetic responses. In addition, vagal 
responsiveness was more favorable in the HRT group, which may indicate that long term 
use of HRT enhances parasympathetic cardiac control.Further, if HRT does influence 
vagal responsiveness, its effects appear to occur in limbic or cortical regions of the 
nervous system. However, due to quasi-experimental design, causal relationships 
between the use of HRT and cardiovascular responses cannot be assumed. 
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 Cardiovascular measurement period 
Sequence A 
 
Baseline 
5 min 
 
Orthostasis Math Speech 
Recovery A 
7 min 
Illusion 
task 
Recovery B 
7 min Stand  Sit  5 * 1 
min 
Prep  Delivery          
5 min 
3 min 3 min 3 min  3 min 
Sequence B 
 
Baseline 
5 min 
 
Orthostasis Speech Math 
Recovery A 
7 min 
Illusion 
task 
Recovery B 
7 min Stand  Sit  Prep  Delivery 
5 * 1 min 5 min 
3 min 3 min 3 min 3 min 
Sequence C 
 
Baseline 
5 min 
 
Orthostasis Illusion task 
Recovery B 
7 min 
Math Speech 
Recovery A  
7 min Stand  Sit  
5 min 5 * 1 min 
Prep  Delivery 
3 min 3 min 3 min 3 min 
Sequence D 
 
Baseline 
5 min 
 
Orthostasis Illusion task 
Recovery B 
7 min 
Speech Math 
Recovery A  
7 min Stand  Sit  
5 min 
Prep  Delivery           
3 min 5 * 1 min 
3 min 3 min 3 min 
 
Figure 1.Diagram of block sequencesacutally administered 
 
 
 
36
 
37 
 
APPENDIX B 
HUMAN SUBJECTS INSTITUTIONAL REVIEW BOARD (IRB) APPROVA
38 
 
 
